USPTO Trademark Registration for CLEARSEE

ChangeBridge: Trademarks - Medical Devices (Class 010)

Published March 20th, 2026

Detected March 25th, 2026

Summary

The USPTO has registered the trademark CLEARSEE for a range of medical apparatus and pharmaceuticals. The registration covers items such as anti-infectives, anti-inflammatories, and medical apparatus for diagnosing or treating various conditions. The filing date for this application was October 15, 2025.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has registered the trademark CLEARSEE (TM79440118) for a broad spectrum of goods. These include various pharmaceutical preparations such as anti-infectives, anti-inflammatories, antibiotics, antivirals, and specialized treatments for cardiovascular, dermatological, respiratory, and autoimmune conditions. Additionally, the registration covers medical apparatus designed for diagnosing or treating respiratory conditions, diabetes, cardiovascular and metabolic disorders, neurological diseases, inflammatory and infectious diseases, and dermatological applications.

This registration signifies the USPTO's approval of CLEARSEE as a protected mark for these goods. While this is a trademark registration and not a regulatory rule, it impacts companies operating in the pharmaceutical and medical device sectors by establishing exclusive rights for the mark owner. Companies involved in these product categories should be aware of this registered trademark to avoid potential infringement issues and to ensure their own branding strategies do not conflict with existing protected marks.

What to do next

Review trademark portfolio for potential conflicts with CLEARSEE
Consult legal counsel regarding any potential CLEARSEE mark usage

Source document (simplified)

← USPTO Trademark Applications

CLEARSEE

Registered TM79440118 Kind: registered Mar 20, 2026

Abstract

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma; Medical apparatus for diagnosing or treating respiratory conditions, diabetes, cardiovascular and metabolic disorders, diseases of the nervous system, inflammatory disorders, infectious diseases and for use in dermatology